▶ MATRIXYL-3000 · SUBTOPIC · DOSING LITERATURE
MATRIXYL-3000 Dosing Literature
For Laboratory Research Use Only. The content below describes dose ranges as reported in peer-reviewed publications. This page does not recommend any dose for human use. No clinical claim is made. Always consult the original source publication.
SCOPE OF THIS PAGE
This page documents the published-literature dose ranges that appear in trials and animal studies of MATRIXYL-3000. Every dose mention is bound to a citation (author, year, PMID where available). The PEPPUDEX wiki phrases these as descriptive observations of the research record, not as instructions to the reader.
ROUTES OF ADMINISTRATION IN PUBLISHED RESEARCH
The published research record for MATRIXYL-3000 reports the following route(s) of administration: Topical (cosmetic). Route selection in a study reflects pharmacokinetic considerations specific to that protocol and is not a recommendation for any human use of MATRIXYL-3000.
PHARMACOKINETIC HALF-LIFE
Published pharmacokinetic data report a half-life for MATRIXYL-3000 of approximately n/a · topical · no systemic exposure. Half-life is the kinetic parameter that frames the dosing rhythm chosen in trial design. It is a measurement, not a recommendation.
CITED DOSE RANGES IN THE LITERATURE
The peer-reviewed sources below report dose ranges, frequencies, and durations used in studies of MATRIXYL-3000. Refer to the original publication for full protocol detail.
- Lintner K, Peschard O (2000) reports the MATRIXYL-3000 protocol used in Biologically active peptides: from a laboratory bench curiosity to a functional skin care product, published in Int J Cosmet Sci. See the source for the protocol-level dose range, frequency, and duration. link
- Robinson LR, Fitzgerald NC, Doughty DG, Dawes NC, Berge CA, Bissett DL (2005) reports the MATRIXYL-3000 protocol used in Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin, published in Int J Cosmet Sci. See the source for the protocol-level dose range, frequency, and duration. link
DOSING Q+A FROM LITERATURE
The questions below summarise dosing-relevant entries from the literature record. Each answer is descriptive of published material and is not a recommendation.
▶ How long does Matrixyl-3000 take to show results?
Collagen synthesis is a slow process. Published trials report measurable improvements at 8-12 weeks of twice-daily topical application. Effects are dose- and duration-dependent.
STORAGE OF THE REFERENCE COMPOUND
Lyophilized · Room temperature, light-protected
Reconstituted · n/a · supplied in cream/serum vehicle
Storage conditions describe the stability of the research-grade reference material, not a dosing protocol.
RECONSTITUTION MATH (CALCULATOR)
The PEPPUDEX reconstitution calculator at /calculator returns volume-per-dose math given vial mg, BAC mL, and a target dose in mcg. The calculator performs arithmetic only. It does not recommend a dose. Any number entered by a researcher must come from their own protocol design or the cited literature.
REGULATORY CONTEXT
FDA · Cosmetic ingredient · not a drug. No FDA pharmaceutical approval required for topical cosmetic use.
WADA · Not listed on the WADA Prohibited List (cosmetic ingredient, no systemic exposure).
RELATED PAGES
▶ LAST UPDATED · 2026-05-25